Finance
Results: 34897-34908 of 40525

TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously

‘Hilton for Business’ Transforms the Travel Management Experience for Small- and Medium-Sized Businesses

New McAfee Global Small Business Study Reveals Concerns, Knowledge and Vulnerabilities of Small Businesses in Today’s Cyber Landscape







